Article | Published:

Dietitian-led lifestyle modification programme for obese Chinese adolescents with non-alcoholic fatty liver disease: a randomized controlled study

International Journal of Obesity (2018) | Download Citation



The prevalence of non-alcoholic fatty liver disease (NAFLD) in children is increasing. This study evaluated the efficacy of a dietitian-led lifestyle modification programme (D-LMP) to reduce NAFLD in obese adolescents.


Subjects with intra-hepatic triglyceride content (IHTC) equal to or greater than 5% diagnosed by proton-magnetic resonance spectroscopy (1H-MRS) were enroled and randomly assigned to either the D-LMP intervention or conventional paediatrician-led consultation (P-CON) group. Subjects in the P-CON group received usual care consisting of a consultation by a paediatrician with the child and parents every 16 weeks. Intention-to-treat analysis was used for data analysis.


Fifty-two subjects were recruited, with 26 in each group. After the initiation phase (at week-16), there was a greater difference in the change in the IHTC and BMI z-score in the D-LMP group (P = 0.029 and <0.001, respectively) and there was a decrease in dietary intake of fat content (P = 0.019). After 52 weeks of the maintenance phase, both groups had reductions of IHTC to 2–3% and there was no intergroup difference in the rate of reduction. During the maintenance phase, parents’ involvement was minimal in the D-LMP group, with only three parents accompanying their children to attend the dietitian sessions. In contrast, over 90% of the parents in the P-CON group regularly accompanied their children to attend the consultations suggesting the possibility that regular parental and paediatrician involvement may contribute to increasing awareness on fatty liver complications. Multivariate analysis showed that only reduction in body fat remained as an independent factor associated with remission of NAFLD at the end of both study phases.


A dietitian-led lifestyle modification intervention reduced IHTC, BMI z-score and body fat in obese Chinese adolescents with NAFLD. To sustain the effect of this intervention, regular parental and paediatrician involvement may be important.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from $8.99

All prices are NET prices.


  1. 1.

    Widhalm K, Ghods E. Nonalcoholic fatty liver disease: a challenge for pediatricians. Int J Obes. 2010;34/10:1451–67.

  2. 2.

    Tominaga K, Kurata JH, Chen YK, Fujimoto E, Miyagawa S, Abe I. et al. Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Dig Dis Sci. 1995;40/9:2002–9.

  3. 3.

    Quiros-Tejeira RE, Rivera CA, Ziba TT, Mehta N, Smith CW, Butte NF. Risk for nonalcoholic fatty liver disease in Hispanic youth with BMI > or = 95th percentile. J Pediatr Gastroenterol Nutr. 2007;44/2:228–36.

  4. 4.

    Chan DF, Li AM, Chu WC, Chan MH, Wong EM, Liu EK. et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord. 2004;28/10:1257–63.

  5. 5.

    Alisi A, Locatelli M, Nobili V. Nonalcoholic fatty liver disease in children. Curr Opin Clin Nutr Metab Care. 2010;13/4:397–402.

  6. 6.

    Hsu E, Murray K. Is nonalcoholic fatty liver disease in children the same disease as in adults?. Clin Liver Dis. 2012;16/3:587–98.

  7. 7.

    Patton HM, Sirlin C, Behling C, Middleton M, Schwimmer JB, Lavine JE. Pediatric nonalcoholic fatty liver disease: a critical appraisal of current data and implications for future research. J Pediatr Gastroenterol Nutr. 2006;43/4:413–27.

  8. 8.

    Mencin AA, Lavine JE. Advances in pediatric nonalcoholic fatty liver disease. Pediatr Clin North Am. 2011;58/6:1375–92.

  9. 9.

    Mager DR, Patterson C, So S, Rogenstein CD, Wykes LJ, Roberts EA. Dietary and physical activity patterns in children with fatty liver. Eur J Clin Nutr. 2010;64/6:628–35.

  10. 10.

    Wong VW, Chan RS, Wong GL, Cheung BH, Chu WC, Yeung DK. et al. Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial. J Hepatol. 2013;59/3:536–42.

  11. 11.

    Nobili V, Manco M, Devito R, Di CV, Comparcola D, Sartorelli MR. et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology. 2008;48/1:119–28.

  12. 12.

    Wang CL, Liang L, Fu JF, Zou CC, Hong F, Xue JZ. et al. Effect of lifestyle intervention on non-alcoholic fatty liver disease in Chinese obese children. World J Gastroenterol. 2008;14/10:1598–602.

  13. 13.

    van der Heijden GJ, Wang ZJ, Chu ZD, Sauer PJ, Haymond MW, Rodriguez LM, et al. A 12-week aerobic exercise program reduces hepatic fat accumulation and insulin resistance in obese, Hispanic adolescents. Obesity. 2010;18/2:384–90.

  14. 14.

    Leung SS, Cole TJ, Tse LY, Lau JT. Body mass index reference curves for Chinese children. Ann Hum Biol. 1998;25:169–74.

  15. 15.

    Chan NP, Sung RY, Nelson EA, So HK, Tse YK, Kong AP. Measurement of pubertal status with a Chinese Self-report Pubertal Development Scale. Matern Child Health J. 2009;14:466–73.

  16. 16.

    Wheeler ML, Franz M, Barrier P, Holler H, Cronmiller N, Delahanty LM. Macronutrient and energy database for the 1995 Exchange Lists for Meal Planning: a rationale for clinical practice decisions. J Am Diet Assoc. 1996;96/11:1167–71.

  17. 17.

    U.S. Department of Health and Human Services and U.S. Department of Agriculture. 2015-20 Dietary Guidelines for Americans. 8th ed. December 2015. Available at:

  18. 18.

    American Gastroenterological Association. American Gastroenterological Association medical position statement: evaluation of liver chemistry tests. Gastroenterology. 2002;123/4:1364–6.

  19. 19.

    Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol. 1999;94/9:2467–74.

  20. 20.

    Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G. et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85/7:2402–10.

  21. 21.

    Kelly SA, Melnyk BM. Systematic review of multicomponent interventions with overweight middle adolescents: implications for clinical practice and research. World Evid Based Nurs. 2008;5/3:113–35.

  22. 22.

    Conn VS, Koopman RJ, Ruppar TM, Phillips LJ, Mehr DR, Hafdahl AR. Insulin sensitivity following exercise interventions: systematic review and meta-analysis of outcomes among healthy adults. J Prim Care Community Health. 2014;5/3:211–22.

  23. 23.

    Manco M, Marcellini M, Devito R, Comparcola D, Sartorelli MR, Nobili V. Metabolic syndrome and liver histology in paediatric non-alcoholic steatohepatitis. Int J Obes. 2008;32/2:381–7.

  24. 24.

    Haflidadottir S, Jonasson JG, Norland H, Einarsdottir SO, Kleiner DE, Lund SH, et al. Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease. BMC Gastroenterol. 2014;14:166.

  25. 25.

    Targher G, Byrne CD, Lonardo A, Zoppini G, Barbui C. Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis. J Hepatol. 2016;65/3:589–600.

  26. 26.

    Younossi ZM, Blissett D, Blissett R, Henry L, Stepanova M, Younossi Y, et al. The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe. Hepatology. 2016;64/5:1577–86.

  27. 27.

    Centre for Health Protection. Overweight and obesity. Hong Kong: Department of Health, Government of the Hong Kong Special Administrative Region; 2017.

  28. 28.

    Wong VW, Chu WC, Wong GL, Chan RS, Chim AM, Ong al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut. 2012;61/3:409–15.

Download references


The project was funded by a grant from the Health and Medical Research Fund, Food and Health Bureau, Hong Kong SAR Government (Ref. no: 11122981) and the Direct Grant for Research (Ref. no: 2014.1.065). The authors thank all the subjects and their parents who participated in the study.

Author contributions

D.F.Y.C. contributed to the study hypothesis, study design and analyses, writing of the manuscript and sharing of scientific discussion. H.K.S. carried out the data analysis and wrote the first draft of the manuscript. S.C.N.H. and W.C.W.C. contributed to the design of 1H-MRS imaging, analysis of IHCT and AAT volume. E.A.S.N. and R.S.M.C. made significant contribution to the conceptual development and review of the manuscript. All authors were involved in the interpretation of the results, revised the manuscript, and read and approved the final version.

Author information


  1. Department of Paediatrics, The Chinese University of Hong Kong, Hong Kong, China

    • D. F. Y. Chan
    • , A. M. Li
    •  & E. A. S. Nelson
  2. Department of Paediatrics and Adolescent Medicine, , The University of Hong Kong, Hong Kong, China

    • H. K. So
  3. Imaging and Interventional Radiology, The Chinese University of Hong Kong, Hong Kong, China

    • S. C. N. Hui
    •  & W. C. W. Chu
  4. Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China

    • R. S. M. Chan
    • , M. M. Sea
    •  & J. Woo
  5. Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, China

    • M. Chan


  1. Search for D. F. Y. Chan in:

  2. Search for H. K. So in:

  3. Search for S. C. N. Hui in:

  4. Search for R. S. M. Chan in:

  5. Search for A. M. Li in:

  6. Search for M. M. Sea in:

  7. Search for W. C. W. Chu in:

  8. Search for M. Chan in:

  9. Search for J. Woo in:

  10. Search for E. A. S. Nelson in:

Conflict of interest

The authors declare that they have no conflict of interest.

Corresponding author

Correspondence to D. F. Y. Chan.

About this article

Publication history